Goldman Sachs on Wednesday opened coverage of Wolters Kluwer with a Neutral stance and set a €71 price target for the Dutch provider of information services. The firm described the stock as carrying an undemanding valuation but lacking obvious short-term catalysts that would support a meaningful rerating.
Analysts led by Adam Berlin project that Wolters Kluwer will remain a dependable compounder, forecasting an earnings per share (EPS) compound annual growth rate (CAGR) near 9% over the 2026-2030 period. Despite that EPS outlook, Goldman's revenue projections sit below market consensus, and the team does not expect an acceleration in organic growth. Instead, they anticipate organic growth to remain broadly steady at about 5% per year.
The bank contrasted Wolters Kluwer with peer RELX, where Goldman sees a clearer path to uplift driven by generative AI product rollouts. Using a proprietary structural AI moat framework, Goldman assigned Wolters Kluwer a score of 6.8 out of 10, compared with 9.0 for RELX. The analysts noted that 44% of Wolters Kluwer's group EBIT is housed in divisions with an AI score below 6, underlining exposure to competitive pressure from AI-driven entrants.
Goldman singled out the Health segment, which accounts for 29% of group EBIT, as an area of particular concern. The bank questioned the pricing power of Wolters Kluwer's flagship clinical product UpToDate amid the emergence of free AI-native competitors. Goldman pointed to OpenEvidence as an example, noting the company has raised $735 million, carries a recent valuation of $12 billion and counts 65% of US physicians among its users - factors the analysts see as challenging UpToDate's traditional monetisation dynamics. They added that hospital IT budgets are expected to remain tight, which could further constrain the ability to monetise Wolters Kluwer's own AI features.
In Tax & Accounting, Goldman constructed an illustrative US market model indicating that addressable spend by tax professionals could slow toward low-single-digit growth. The bank attributes this expected deceleration to DIY tax solutions powered by AI reducing demand for professionally prepared returns, and forecasts organic growth for the segment to moderate to roughly 5-6%, down from the high-single-digit rates of recent years.
The Legal & Regulatory division received a more favorable structural assessment, with Goldman observing that its products are embedded in lawyer workflows where outputs must be authoritative and citable. Nevertheless, the analysts raised doubts about whether Wolters Kluwer's AI investments will be sufficient to fend off better-capitalised competitors. They specifically questioned whether the company's €90 million acquisition of Libra - a startup with 15 employees - will provide enough scale or capability given the resources other players are deploying.
On valuation, Goldman described Wolters Kluwer's current multiple as undemanding but emphasised the scarcity of catalysts likely to produce a re-rating. In short, the bank views the company as a quality operator with solid EPS growth potential, while remaining cautious about the risk that AI-driven competitors and constrained customer budgets may limit revenue upside in key segments.
Summary
Goldman initiates coverage of Wolters Kluwer with a Neutral rating and a €71 price target. Analysts see steady EPS growth but expect organic revenue growth to remain around 5% annually. They highlight AI-related competitive risks, particularly in Health and Tax & Accounting, and consider the companys valuation undemanding but lacking clear re-rating catalysts.
Key points
- Goldman projects EPS CAGR near 9% through 2026-2030 while forecasting organic revenue growth of about 5% annually.
- AI competition is a central concern - Goldmans structural AI moat score for Wolters Kluwer is 6.8/10, with 44% of group EBIT in businesses scoring below 6.
- Health, Tax & Accounting, and Legal & Regulatory segments face differing structural prospects: Health and Tax & Accounting show heightened exposure to AI disruption, while Legal & Regulatory remains more embedded in workflows but may still lack sufficient AI investment scale.
Risks and uncertainties
- Rapid adoption of free AI-native tools could undermine pricing power for flagship products such as UpToDate - a material risk for the Health segment and hospital IT spend.
- DIY tax solutions powered by AI may reduce demand for professionally prepared returns, slowing Tax & Accounting revenue growth toward low-single-digit rates.
- Wolters Kluwers modest AI investments, including the €90 million acquisition of Libra, may be insufficient to compete with better-funded rivals in Legal & Regulatory and other areas.